Pharmafile Logo
Pharmafocus logo
Advanced Search

cystic fibrosis

Showing 13 posts of 43 posts found.

AbbVie

Galapagos and AbbVie in $405m cystic fibrosis deal

September 25, 2013
Research and Development, Sales and Marketing AbbVie, Galapagos, cystic fibrosis

News

NICE recommends two cystic fibrosis treatments

January 25, 2013
Sales and Marketing Colobreath, Forest Labs, Novartis, Tobi Podhaler, cystic fibrosis

NICE has given final recommendation to two new inhalers for cystic fibrosis (CF) patients.Forest Lab’s Colobreath (colistimethate sodium) and Novartis’ …

News

Vertex admits blunder over drug data

May 31, 2012
Sales and Marketing Kalydeco, Kalydeco., Vertex, cystic fibrosis

Vertex has been embarrassed after it released claims for its pipeline drug VX-809 which turned out to be incorrect. The …

News

Landmark CF treatment set for European approval

May 30, 2012
Sales and Marketing CHMP, Europe, Kalydeco, Vertex, cystic fibrosis

A European committee is recommending the approval of Vertex’s first-in-class treatment for cystic fibrosis.  Kalydeco (ivacaftor) is a landmark in …

News

Groundbreaking CF drug recommended in Europe

May 25, 2012
Sales and Marketing CHMP, EMA, Kalydeco, Vertex, cystic fibrosis

The first-in-class treatment for cystic fibrosis Kalydeco has been recommended by the EMA’s medicines committee. Kalydeco (ivacaftor) promises to be …

News

Kalydeco to be landmark in cystic fibrosis treatment

February 1, 2012
Vertex, cystic fibrosis, telaprevir

Vertex’s first-in-class treatment for cystic fibrosis Kalydeco has been approved by the FDA. The approval is a landmark in the …

News

Vertex’s cystic fibrosis drug shows huge promise

February 28, 2011
Research and Development, Sales and Marketing VX-770, Vertex, cystic fibrosis

US pharma company Vertex has announced extremely promising results for a drug that could be a major advance in treating …

News

Pfizer acquires ‘protein misfolding’ specialist

September 2, 2010
Research and Development FoldRx, Pfizer, cystic fibrosis

Pfizer has bolstered its presence in rare and orphan diseases with the acquisition of FoldRx, a US drug discovery firm …

News

Gilead is latest drugmaker in FDA’s sights

August 13, 2010
Manufacturing and Production Gilead, cystic fibrosis, manufacturing compliance

A manufacturing and distribution facility operated by US biotech Gilead Sciences is at risk of receiving a warning letter from …

News

Lilly set to acquire Alnara Pharmaceuticals

July 5, 2010
Research and Development, Sales and Marketing Alnara, Liprotamase, cystic fibrosis, enzyme replacement therapy, lilly

Lilly is to acquire US-based biotech firm Alnara and will take hold of its lead product Liprotamase for pancreatic enzyme …

News
Blog footer

Digital Pharma: Novartis tells cystic fibrosis stories

February 25, 2010
Medical Communications Novartis, cystic fibrosis, digi, digi pharma, social media

Novartis has launched a new disease awareness campaign for cystic fibrosis that blurs the lines between fact and fiction. Its …

News

Sanofi Pasteur collaborates on novel biologics

January 12, 2010
Research and Development KaloBios, Sanofi, Sanofi Pasteur, cystic fibrosis, infection, vaccines

Sanofi Aventis’ vaccines division has partnered with US biotech KaloBios to develop a number of novel biologic treatments. Sanofi Pasteur …

News

Abbott buys Solvay for $6.6 billion

September 28, 2009
Sales and Marketing Abbott, Solvay, cystic fibrosis

Abbott is to buy the pharma division of Belgium-based Solvay for 4.5 billion euros ($6.6 billion) in cash.Solvay declared in …

News

Latest content

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024

AskBio initiates phase 2 Parkinson’s trial recruitment

June 26, 2024

AstraZeneca’s Tagrisso approved in Japan for lung cancer treatment

June 25, 2024